Articles by Disease (Sepsis-associated Encephalopathy)

Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection

Journal: Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)
Volume: 2
Page: 79-88
Author(s): Pádraic J. Dunne, Georgia Richard and Joseph Keane

Mechanisms And Prevention Of TAVI-Related Cerebrovascular Events

Journal: Current Pharmaceutical Design
Volume: 22
Page: 1879-1887
Author(s): Alexander Ghanem, Amir S. Naderi, Christian Frerker, Georg Nickenig and Karl-Heinz Kuck

Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review

Journal: Current Medicinal Chemistry
Volume: 23
Page: 667-685
Author(s): Gergő A. Molnár, Szilárd Kun, Eszter Sélley, Melinda Kertész, Lívia Szélig, Csaba Csontos, Katalin Böddi, Lajos Bogár, Attila Miseta and István Wittmann

Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases

Journal: Current Medicinal Chemistry
Volume: 23
Page: 714-745
Author(s): Sarmistha Basak, Chunyu Lu and Ajoy Basak

Cysteine Network (CYSTEINET) Dysregulation in Parkinson’s Disease: Role of N-acetylcysteine

Journal: Current Drug Metabolism
Volume: 17
Page: 368-385
Author(s): Marcos Martínez-Banaclocha

Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?

Journal: Current Pharmaceutical Design
Volume: 22
Page: 1324-1333
Author(s): Valentina Echeverria, J. Alex Grizzell and George E. Barreto

Evolving Insights into the Pathophysiology of Diabetic Neuropathy: Implications of Malfunctioning Glia and Discovery of Novel Therapeutic Targets

Journal: Current Pharmaceutical Design
Volume: 22
Page: 738-757
Author(s): Md Habibur Rahman, Mithilesh Kumar Jha and Kyoungho Suk